Positive pressure ventilation treatment reduces plasma levels of amino terminal-pro brain natriuretic peptide in congestive heart failure patients with sleep apnea

Circulation Journal

Volumn 70, Issue 5, 2006, Pages 572-574

  Zhao, Zhi Hui ^a   Liu, Zhi Hong ^a   Luo, Qin ^a   Xiong, Chang Ming ^a   Ni, Xin Hai ^a   Zhang, Jian ^a   Zhang, Shu ^a   Yang, Yue Jin ^a  

^a FUWAI HOSPITAL   (China)

Author keywords

Congestive heart failure; Positive pressure ventilation; Sleep apnea

Indexed keywords

AMINO TERMINAL PRO BRAIN NATRIURETIC PEPTIDE; BRAIN NATRIURETIC PEPTIDE; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CLINICAL TRIAL; CONGESTIVE HEART FAILURE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; POLYSOMNOGRAPHY; POSITIVE END EXPIRATORY PRESSURE; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; SLEEP APNEA SYNDROME; TREATMENT OUTCOME;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; NATRIURETIC PEPTIDE, BRAIN; PEPTIDE FRAGMENTS; POLYSOMNOGRAPHY; SLEEP APNEA SYNDROMES; VENTILATION;

EID: 33646111902     PISSN: 13469843     EISSN: 13474820     Source Type: Journal    
DOI: 10.1253/circj.70.572     Document Type: Article

References (10)

1. Bradley TD, Floras JS. Sleep apnoea and heart failure: Part I: Obstructive sleep apnea. Circulation 2003; 107: 1671-1678.
2. Ogawa A, Iwase T, Yamamoto T, Nishiyama S, Narui K, Momomura S. Improvement of Cheyne-Stokes respiration, central sleep apnea and congestive heart failure by noninvasive bi-level positive pressure and medical treatment. Circ J 2004; 68: 878-882.
3. Bradley TD, Logan AG, Kimoff RJ, Sériès F, Morrison D, Ferguson K, the CANPAP Investigators. Continuous positive airway pressure for central sleep apnea and heart failure. N Engl J Med 2005; 353: 2025-2033.
4. Fonseca C, Sarmento PM, Minez A, Goncalves E, Covas R, Dias AR, et al. Comparative value of BNP and NT-proBNP in diagnosis of heart failure. Rev Port Cardiol 2004; 23: 979-991.
5. Richards M, Troughton RW. NT-proBNP in heart failure: Therapy decisions and monitoring. Eur J Heart Fail 2004; 6: 351-354.
6. Javaheri S, Parker TJ, Liming JD, Corbett WS, Nishiyama H, Wexler L, et al. Sleep apnea in 81 ambulatory male patients with stable heart failure: Types and their prevalence, consequences, and presentations. Circulation 1998; 97: 2154-2159.
7. Sin DD, Fitzgerald F, Parker JD, Newton G, Floras JS, Bradley TD. Risk factors for central and obstructive sleep apnea in 450 men and women with congestive heart failure. Am J Respir Crit Care Med 1999; 160: 1101-1106.
8. Kaneko Y, Floras JS, Usui K, Plante J, Tkacova R, Kubo T, et al. Cardiovascular effects of continuous positive airway pressure in patients with heart failure and obstructive sleep apnea. N Engl J Med 2003;348: 1233-1241.
9. Pepperell JC, Maskell NA, Jones DR, Langford-Wiley BA, Crosthwaite N, Stradling JR, et al. A randomized controlled trial of adaptive ventilation for Cheyne - Stokes breathing in heart failure. Am J Respir Crit Care Med 2003; 168: 1109-1114.
10. Kasai T, Narui K, Dohi T, Ishiwata S, Yoshimura K, Nishiyama SI, et al. Efficacy of nasal bi-level positive airway pressure in congestive heart failure patients with Cheyne-Stokes respiration and central sleep apnea. Circ J 2005; 69: 913-921.